The lower concentration means larger injection volumes for a given dose, which can actually help with accuracy when using standard insulin syringes
Glucagon-Like Peptide 1 Agonists Show Neuroprotective Properties in the Treatment of Other Neurodegenerative Diseases Glucagon-like peptide 1 (GLP-1) and GLP1R agonists have been associated not only with neuroprotection in the retina but also in the brain in various animal models of neurodegenerative diseases (Zhang et al., 2018, 2019
Limit or avoid candy, desserts, sugary drinks, soda, etc
Staying on GLP-1 drugs has been a persistent challenge for patients
No effort
In the past decade, CVOTs with GLP-1RAs have been conducted with at least seven agents including liraglutide, lixisenatide, exenatide, semaglutide, dulaglutide, albiglutide and oral semaglutide (Table 2)